Maturing iPSC-Derived Cardiomyocytes

被引：12
|
作者：
Tang, Bor Luen [1 ,2 ]
机构：
[1] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117596, Singapore
[2] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 119077, Singapore
来源：
CELLS | 2020年 / 9卷 / 01期
关键词：
PLURIPOTENT STEM-CELLS; MATURATION;
D O I：
10.3390/cells9010213
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] iPSC-Derived Cardiomyocytes as a Disease Model to Understand the Biology of Congenital Heart Defects
    Pushpan, Chithra K.
    Kumar, Subramanyan Ram
    CELLS, 2024, 13 (17)
  • [22] Metabolic Maturation Media Improve Physiological Function of Human iPSC-Derived Cardiomyocytes
    Feyen, Dries A. M.
    McKeithan, Wesley L.
    Bruyneel, Arne A. N.
    Spiering, Sean
    Hoermann, Larissa
    Ulmer, Barbel
    Zhang, Hui
    Briganti, Francesca
    Schweizer, Michaela
    Hegyi, Bence
    Liao, Zhandi
    Polonen, Risto-Pekka
    Ginsburg, Kenneth S.
    Lam, Chi Keung
    Serrano, Ricardo
    Wahlquist, Christine
    Kreymerman, Alexander
    Vu, Michelle
    Amatya, Prashila L.
    Behrens, Charlotta S.
    Ranjbarvaziri, Sara
    Maas, Renee G. C.
    Greenhaw, Matthew
    Bernstein, Daniel
    Wu, Joseph C.
    Bers, Donald M.
    Eschenhagen, Thomas
    Metallo, Christian M.
    Mercola, Mark
    CELL REPORTS, 2020, 32 (03):
  • [23] Electro-mechanical conditioning of human iPSC-derived cardiomyocytes for translational research
    Kroll, Katharina
    Chabria, Mamta
    Wang, Ken
    Hausermann, Fabian
    Schuler, Franz
    Polonchuk, Liudmila
    PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2017, 130 : 212 - 222
  • [24] Characterization of cardiac metabolism in iPSC-derived cardiomyocytes: lessons from maturation and disease modeling
    Vuckovic, Sofija
    Dinani, Rafeeh
    Nollet, Edgar E.
    Kuster, Diederik W. D.
    Buikema, Jan Willem
    Houtkooper, Riekelt H.
    Nabben, Miranda
    van der Velden, Jolanda
    Goversen, Birgit
    STEM CELL RESEARCH & THERAPY, 2022, 13 (01)
  • [25] Toxicity testing and drug screening using iPSC-derived hepatocytes, cardiomyocytes, and neural cells
    Csobonyeiova, Maria
    Polak, Stefan
    Danisovic, L'ubos
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2016, 94 (07) : 687 - 694
  • [26] Human iPSC-derived cardiomyocytes and tissue engineering strategies for disease modeling and drug screening
    Smith, Alec S. T.
    Macadangdang, Jesse
    Leung, Winnie
    Laflamme, Michael A.
    Kim, Deok-Ho
    BIOTECHNOLOGY ADVANCES, 2017, 35 (01) : 77 - 94
  • [27] Characterization of cardiac metabolism in iPSC-derived cardiomyocytes: lessons from maturation and disease modeling
    Sofija Vučković
    Rafeeh Dinani
    Edgar E. Nollet
    Diederik W. D. Kuster
    Jan Willem Buikema
    Riekelt H. Houtkooper
    Miranda Nabben
    Jolanda van der Velden
    Birgit Goversen
    Stem Cell Research & Therapy, 13
  • [28] Industrialized Production of Human iPSC-Derived Cardiomyocytes for Use in Drug Discovery and Toxicity Testing
    Anson, Blake
    Nuwaysir, Emile
    Swanson, Brad
    Wang, Wen Bo
    BIOPHARM INTERNATIONAL, 2011, 24 (03) : 58 - +
  • [29] Engineered cocultures of iPSC-derived atrial cardiomyocytes and atrial fibroblasts for modeling atrial fibrillation
    Brown, Grace E.
    Han, Yong Duk
    Michell, Ashlin R.
    Ly, Olivia T.
    Vanoye, Carlos G.
    Spanghero, Emanuele
    George Jr, Alfred L.
    Darbar, Dawood
    Khetani, Salman R.
    SCIENCE ADVANCES, 2024, 10 (03)
  • [30] Co-culture with neonatal cardiomyocytes enhances the proliferation of iPSC-derived cardiomyocytes via FAK/JNK signaling
    Ou, Dongbo
    Wang, Qi
    Huang, Yanjin
    Zeng, Di
    Wei, Ting
    Ding, Lu
    Li, Xiaoli
    Zheng, Qiangsun
    Jin, Yan
    BMC DEVELOPMENTAL BIOLOGY, 2016, 16
12345